Literature DB >> 15541863

Endometriosis with FDG uptake on PET.

Louis Jeffry1, Khaldoun Kerrou, Sophie Camatte, Ulrike Metzger, Loic Lelièvre, Jean-Noel Talbot, Fabrice Lecuru.   

Abstract

BACKGROUND: The value of [18F]fluorodeoxyglucose positron emission tomography (FDG-PET) uptake in endometriosis has not yet been extensively reported. CASE REPORT: A 32-year-old woman was examined to find an explanation for right pelvic pain associated with right subcostal pain. A computerised tomography (CT) scan was compatible with a haemangioma or a focus of endometriosis in the liver. Transvaginal sonography and magnetic resonance imaging (MRI) showed a complex ovarian cyst on the left. Blood CA125 levels were elevated. FDG-PET revealed a focus of uptake in the right paravesical area. Laparoscopy showed a left endometrioma associated with diffuse inflammatory pelvic adhesions. After surgery and 3 months GnRH agonist treatment the pain had disappeared and neither MRI nor FDG-PET showed any pelvic abnormality. The patient subsequently presented with dyspareunia and rectal pain resulting from a right uterosacral nodule and a rectal nodule. These were resected laparoscopically. After a 1-year follow-up, the patient is doing well.
CONCLUSION: Endometriosis can give rise to false-positive results on FDG-PET. However, the FDG uptake in this particular case of endometriosis seems to have been due to inflammation rather than to a cyst. This report highlights the relationship between some of the biological features of endometriosis and some observed in neoplastic lesions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15541863     DOI: 10.1016/j.ejogrb.2004.04.034

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  8 in total

Review 1.  Cesarean-Section Scar Endometrioma: A Case Report and Review of the Literature.

Authors:  Madison Kocher; Andrew Hardie; Amanda Schaefer; Thomas McLaren; Mark Kovacs
Journal:  J Radiol Case Rep       Date:  2017-12-31

2.  Retroperitoneal Endometriosis: A Possible Cause of False Positive Finding at (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.

Authors:  Anna Margherita Maffione; Riccardo Panzavolta; Laura Camilla Lisato; Maria Ballotta; Mariangela Zanforlini D'Isanto; Domenico Rubello
Journal:  World J Nucl Med       Date:  2015 May-Aug

3.  Polypoid endometriosis: a mimic of malignancy.

Authors:  Soleen Ghafoor; Yulia Lakhman; Kay J Park; Iva Petkovska
Journal:  Abdom Radiol (NY)       Date:  2020-06

4.  Ovarian mass mimicking malignancy: a case report.

Authors:  Yong-Il Kim; Seok-Ki Kim; Jeong-Won Lee; Sang Mi Lee; Tae-Sung Kim
Journal:  Nucl Med Mol Imaging       Date:  2010-08-27

5.  (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-positive lymph node endometriosis masquerading as lymph node metastasis of a malignant tumor.

Authors:  Makoto Akiyama; Izumi Suganuma; Taisuke Mori; Izumi Kusuki; Haruo Kuroboshi; Fumitake Ito; Hiroshi Matsushima; Morio Sawada; Jo Kitawaki
Journal:  Case Rep Obstet Gynecol       Date:  2014-08-10

6.  Endometriosis on the surface of the uterus mimicking a malignant tumor: A case report with literature review.

Authors:  Lihong Pang; Honghui Shi; Tao Wang; Lan Zhu; Jinghe Lang; Qingbo Fan; Haiyuan Liu; Xin Yu; Yang Cao; Yu Xiao
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

7.  Pulmonary cavitations with increased 18F-FDG uptake revealing a thoracic endometriosis: A case report.

Authors:  Pauline Mulette; Amaury Jacquet; Anne Durlach; Dimitri Papathanassiou; Paul Lalire; Olivier Graesslin; Gonzague Delepine; Sandra Dury; Valérian Dormoy; Jeanne-Marie Perotin; François Lebargy; Gaëtan Deslée; Claire Launois
Journal:  Medicine (Baltimore)       Date:  2021-10-22       Impact factor: 1.817

8.  Interference of Known or Suspected Endometriosis in Reporting FDG PET/CT Performed in Another Indication.

Authors:  Sona Balogova; Emile Daraï; Lucia Noskovicova; Ludovit Lukac; Jean-Noël Talbot; Françoise Montravers
Journal:  Clin Nucl Med       Date:  2022-04-01       Impact factor: 7.794

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.